Efficacy and Safety of Neoadjuvant Subcutaneous Envafolimab in dMMR/MSI-H Locally Advanced Colon Cancer.
Li Y, Zhang W, Du J, Hu J, Hu R, Zeng Z, Jin-Si-Han EE, Lian S, Wang H, Li Y, Pan Z, Feng C, Zhang X, Lu Z.
Li Y, et al. Among authors: pan z.
Target Oncol. 2024 Apr 30. doi: 10.1007/s11523-024-01064-x. Online ahead of print.
Target Oncol. 2024.
PMID: 38691294